A growing list of companies are exiting the public market to shield themselves from growing regulatory and investor pressure to lift valuations and implement more oversight.
CEO of Salonpas maker seeks to take $2.9 billion drug firm private
Published 1 week ago
Source: japantimes.co.jp
Categories
BUSINESS
Related Articles from japantimes.co.jp
1 hour ago
At Driftwood, cocktails flow to the sounds of city pop
2 hours ago
Takaichi and South Korea’s Lee to take ties to ‘new heights’ amid Japan-China rift
2 hours ago
To realize a circular economy, Oji advances recycling, partnerships
2 hours ago
Amphipod species with panda-like coloring discovered in Wakayama
2 hours ago
Saga University to launch faculty focused on science of cosmetics
2 hours ago